Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
about
Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNAQuality of life: A critical outcome for all surgical treatments of gastric cancerGastric cancer: descriptive epidemiology, risk factors, screening, and preventionADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperonesProfound, prelingual nonsyndromic deafness maps to chromosome 10q21 and is caused by a novel missense mutation in the Usher syndrome type IF gene PCDH15.Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.Nature meets nurture: molecular genetics of gastric cancer.Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.Family history and the risk of gastric cancer.Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentGenomic features defining exonic variants that modulate splicing.Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil.Presymptomatic identification of CDH1 germline mutation in a healthy korean individual with family history of gastric cancer.Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literatureBreast cancer susceptibility: current knowledge and implications for genetic counsellingRisk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control studyE-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X.CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.10 rare tumors that warrant a genetics referral.Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literatureProphylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family.Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature.Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.Lobular breast cancer: incidence and genetic and non-genetic risk factors.Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features.Familial Gastric Cancers.Hereditary diffuse gastric cancer: association with lobular breast cancer.Familial gastric cancer: detection of a hereditary cause helps to understand its etiology.Prevalence of deleterious ATM germline mutations in gastric cancer patientsNovel CDH1 germline mutations identified in Chinese gastric cancer patients.
P2860
Q24320146-329A7D70-3E80-420C-A5A6-8CE1226F2D0DQ26774542-EA6E8095-D268-4BC0-9082-10D44E619FD5Q26849435-A201892F-B5C1-4DF2-886E-282923E2ED09Q28476496-1E671EE6-B285-4C17-8573-530E97B10DE7Q30497402-F9F05AA0-1529-43F3-BE19-AA2FDA5AAA59Q30652890-C1DDDB9E-01EB-4D80-AA6A-BBC701BB3335Q33347546-136D8941-3687-4179-8968-5815ACFB13CAQ33623555-79B00B63-6AFB-44EC-A663-153CA950B36AQ33630778-D383FB72-3B70-4A3C-95E0-87B7E490E169Q33796155-8AAEA3D3-9B79-4706-A18B-2FF79F7CF12BQ33861632-57BBB438-0D7A-48DE-BCCF-551764301710Q33908316-9A918C3E-086E-48F4-8C24-C8D973BA2321Q34112902-A1E73974-8853-42E4-ACAA-A404A67194A2Q34116651-43D1774A-F5D5-484C-B764-6FE91ED74691Q34120710-7289BDB9-C439-434F-8335-5D8C8E1EAE0BQ34161642-B7E25B59-8C14-416C-8A4F-910C91F70176Q34208198-788C0EC7-FF13-49A3-93A8-49E6CD287EC9Q34217518-4235EB33-8A3F-4042-A1FB-C43F342AF734Q34269998-247F2108-E3E8-450A-820F-8DE38C3BD880Q34306552-A0AC0AC9-0C66-453F-BA42-344D9F5B1350Q34325954-90D24E67-1AA1-4A96-8771-CCEF570D1ABBQ34346468-E0C1D88D-6644-4E5C-9406-01CEECFBCE37Q34414768-37970B26-B1E4-41E7-9B70-E9F631348FC6Q34521706-0EBE89BA-8B8C-4988-A309-D27B6D30353FQ34572734-CF24E0C5-F087-4F4F-94A5-AD1F81072050Q34582435-B910A072-06F1-4E0A-A0A8-B9FEAF8FC215Q34815548-CA26EBE5-1FDD-47B4-B693-001DFFC45630Q34983702-AE00E9D7-64FF-49F3-9197-A7EA8C08C219Q35077001-A862DD61-D45D-4D60-947E-2EC422035719Q35082507-970549C9-6E40-47B4-B866-EAC088F32C5FQ35170028-F3A6B9CD-04F8-4DE3-A76E-BDE966268E09Q36101775-C8CC9311-C7C7-406D-96F3-177BF187E457Q36162532-F9F69B04-7FE5-41B2-90F8-8174753A4546Q36269737-9920702F-37AB-4407-9EFF-2B2A6C49D22FQ36295215-D15658C2-3720-44AE-99FC-53223213D1D1Q36371610-C3DF7BF9-5CC9-44EE-AF06-492D67B82551Q36477282-A65515E5-A272-45C1-A544-E1CE633405ECQ36541982-D01981A7-927B-494C-8179-71672FEEBD5DQ36562231-36348FFA-6068-49B4-8443-6E9D9163AD56Q36616837-3D736BE4-D261-4788-8E1E-5EF1E4E49926
P2860
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@en
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@nl
type
label
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@en
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@nl
prefLabel
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@en
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@nl
P2093
P50
P356
P1476
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
@en
P2093
Alessandro De Luca
Andrée MacMillan
Benoit Panzini
Bridget Fernandez
Cathy Gilpin
Courtney Sebold
Daniel Chung
Daniel Coit
Daniel Fontaine
David Huntsman
P304
P356
10.1001/JAMA.297.21.2360
P407
P577
2007-06-03T00:00:00Z